NanoBio First - Funding Program for World-Leading Innovative R&D on Science and Technology_[Development of Innovative Diagnostic and Therapeutic Systems Based on Nanobiotechnology] NanoBio First Japanese

NanoBio-First Website

Researcher data

Nobuhiro NISHIYAMA

Nobuhiro NISHIYAMA
Sub-project III Leader

Nanocarrier-mediated imaging and therapy of malignant tumors

Recently, medical devices such as MRI has made great advances. In this Outline, we design supramolecular nanocarriers for the delivery of imaging agents and sensitizers. The combination of medical devices and nanocarriers allows early detection of small pathological changes and pin-point treatment of the diseased sites without damaging normal tissues, improving the quality of life (QOL) of the patients.

Affiliation Polymer Chemistry Division, Chemical Resources Laboratory,
Tokyo Institute of Technology
Specialty Drug Delivery System, Biomedical Engineering
URL  
TEL 03-5841-0246
FAX 03-5841-1419
MAIL NISHIYAMA's e-mail address
Address 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033 Japan

NanoBio First - Funding Program for World-Leading Innovative R&D on Science and Technology
- Development of Innovative Diagnostic and Therapeutic Systems Based on Nanobiotechnology

Copyright (C) 2010 NanoBio First All Rights Reserved.